Hydromorphone Hydrochloride Injection — FDA Drug Shortage

Current — Hospira, Inc., A Pfizer Company

The FDA lists a drug shortage record for Hydromorphone Hydrochloride Injection (injection) from Hospira, Inc., A Pfizer Company with status Current. The shortage was first posted on Oct 31, 2017. Reported reason: Demand increase for the drug

Shortage details

Status
Current
Company
Hospira, Inc., A Pfizer Company
Package NDC
0409-1283-31
Dosage Form
Injection
Presentation
Hydromorphone Hydrochloride, Injection, 1 mg/1 mL Syringes (NDC 0409-1283-31)
Initial Posting
Oct 31, 2017

Reason

Demand increase for the drug

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.